Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medication Therapy Management To Expand In Part D Under CMS Rule

Executive Summary

CMS expects the proposed changes to medication therapy management will make 55% of Medicare beneficiaries eligible for MTM services, which CMS says has been shown to improve drug therapy outcomes and reduce health care costs.


Related Content

CBO Legislative Scores Will Account For Medicare Rx’s Reductions In Other Medical Costs
Policy Changes In Part D Could Improve Patients’ Rx Adherence, Professor Argues





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts